Search results
Added:
3 years ago
Heart failure (HF) affects more than 2% of the adult population worldwide; it is responsible for about 1 million hospitalisations per year in the US and it carries a high mortality risk.1 Recent population data indicate overall better survival rates, albeit with greater healthcare costs.1 Altogether, HF syndrome represents one of the biggest challenges to modern medicine, and places an enormous…
View more
Added:
2 years ago
Heart Failure Management in a Changing Paradigm
Video Series
Added:
4 years ago
Heart failure (HF) is a global epidemic which affects about 6 million adults in the US. It is projected that by 2030 the total cost of HF will reach US$70 billion. Despite the development of novel drugs and devices, the mortality burden of HF remains high, with one in three patients dying within 1 year of hospitalisation for HF and 40–50% within 5 years of diagnosis.1
Patients with HF are…
View more
Added:
1 year ago
This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice.
In this third and final discussion of the series, Dr Mikhail Kosiborod(Saint Luke’s Mid America Heart Institute, US) and Dr Shelley Zieroth (St Boniface Hospital, Winnipeg, CA)discuss the adoption of patient reported outcomes in…
View more
Added:
3 years ago
Telehealth is a multiform term embracing the applications of telematics to medicine, in order to enable diagnosis and/or treatment remotely through a set of communication tools, including phones, smartphones and mobile wireless devices, with or without a video connection.1
Until a few years ago, digital applications in medicine were restricted to the use of data obtained from electronic health…
View more
Added:
4 years ago
Prof Martin Cowie (Imperial College London, London, UK) discusses practical usage of HeartLogic and RPM in the healthcare system today - view of integration of HeartLogic in the clinical workflow.
This interview was supported by Boston Scientific
Filmed on site at HFA 2019 by Radcliffe Cardiology
Videography: Mike Knight, Tom Green
Interviewer: Liam O'Neill
View more
Added:
1 year ago
This series of peer-to-peer discussions examines the practicalities of personalising heart failure management in the context of recent changes to international clinical practice guidelines.
At this exciting juncture, we now have two SGLT-2 inhibitors that offer clinical benefit across the spectrum of ejection fraction, and an increasing body of real-world and registry-based data showing…
View more
Added:
3 years ago
Primarily due to significant treatment advancements to prevent previously fatal acute cardiac events, the burden of heart failure (HF), characterised by chronic symptoms, acute hospitalisations and premature mortality, continues to rise.1,2 Latest expert guidelines3,4 confirmed by meta-analyses5,6 support the application of multidisciplinary HF management programs to improve health outcomes…
View more
Added:
3 years ago
The specialised role of the heart failure nurse rose to prominence during the 1990s. Studies of heart failure disease management reported a reduction in the risk of hospital readmission in services with structured follow up that focused on the optimisation of therapy, out-patient follow up, education for self-care and the coordination of care.1 Nurses had already established their role in the…
View more
